M
Medpace Holdings, Inc. (MEDP)
NMS – Real Time Price. Currency in USD
451.20
-15.40 (-3.30%)
At close: Mar 27, 2026, 4:00 PM EDT
451.79
+0.59 (0.13%)
After-hours: Mar 27, 2026, 7:38 PM EDT
Get all premium features to the best stock analysis tool
NMS – Real Time Price. Currency in USD
451.20
-15.40 (-3.30%)
At close: Mar 27, 2026, 4:00 PM EDT
451.79
+0.59 (0.13%)
After-hours: Mar 27, 2026, 7:38 PM EDT
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
| Name | Position |
|---|---|
| Dr. August James Troendle M.D. | Chairman & CEO |
| Mr. Brandon Ebken | Chief Information Officer |
| Mr. Jesse J. Geiger BBA, CPA | President |
| Mr. John T. Wynne MBA | Senior Vice President of Commercial Operations & Clinical Pharmacology Unit |
| Mr. Kevin M. Brady | CFO & Treasurer |
| Mr. Stephen P. Ewald J.D. | Chief Compliance Officer, General Counsel & Corporate Secretary |
| Mr. Todd Meyers | Vice President of Business Development & Marketing |
| Date | Type | Document |
|---|---|---|
| 2026-03-16 | PRE 14A | medp-20260316.htm |
| 2025-10-23 | 10-Q | medp-20250930.htm |
| 2025-10-22 | 8-K | medp-20251022.htm |
| 2025-07-22 | 10-Q | medp-20250630.htm |
| 2025-07-21 | 8-K | medp-20250717.htm |
| 2025-05-16 | 8-K | d918670d8k.htm |
| 2025-04-22 | 10-Q | medp-20250331.htm |
| 2025-04-21 | 8-K | medp-20250417.htm |
| 2025-04-02 | DEF 14A | medp-20250402.htm |
| 2025-03-31 | 8-K | medp-20250328.htm |
| Mr. Weimin Gai MS |
| Senior Vice President of Biometrics |
| Ms. Lauren Morris | Associate Director of Investors Relations |
| Ms. Susan E. Burwig BSN, MA | Executive Vice President of Operations |